[
  {
    "variant_id": {
      "Gene": "Parkin",
      "Protein_Change": {
        "ref": "Q",
        "alt": "R",
        "position": "240"
      },
      "variant_string_id": "Parkin Q240R"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes that the PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations, implicating Parkin in the pathogenesis of Parkinson's disease.",
        "judgment": "Yes",
        "reasoning": "The text explicitly states that PD-associated mutations compromise the PINK1/Parkin-mediated mitophagy, which is a key mechanism in Parkinson's disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The authors used a functional complementation assay to assess the ability of wild-type and mutant Parkin proteins to rescue cell death induced by mitochondrial dysfunction.",
        "judgment": "Yes",
        "reasoning": "The general class of assay, functional complementation, effectively models or reflects the disease pathogenesis/mechanism defined in Step 1 (mitophagy is impaired in Parkinson's disease, and functional complementation assesses the ability of Parkin to rescue mitochondrial dysfunction)."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The authors used wild-type and mutant Parkin proteins, performed experiments in triplicate, and used known gain-of-function mutants as positive controls."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The authors calculated OddsPath for the Q240R Parkin variant, which was found to be 16.7."
      }
    ],
    "functional_evidence_strength": "PS3_very_strong"
  },
  {
    "variant_id": {
      "Gene": "PINK1",
      "Protein_Change": {
        "ref": "-",
        "alt": "+",
        "position": "620"
      },
      "variant_string_id": "PINK1 +620"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes that the PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations, implicating PINK1 in the pathogenesis of Parkinson's disease.",
        "judgment": "Yes",
        "reasoning": "The text explicitly states that PD-associated mutations compromise the PINK1/Parkin-mediated mitophagy, which is a key mechanism in Parkinson's disease."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The authors used a yeast complementation assay to assess the ability of wild-type and mutant PINK1 proteins to interact with endogenous Parkin.",
        "judgment": "Yes",
        "reasoning": "The general class of assay, protein interaction, effectively models or reflects the disease pathogenesis/mechanism defined in Step 1 (mitophagy is impaired in Parkinson's disease, and protein interaction assesses the ability of PINK1 to interact with Parkin)."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The authors used wild-type and mutant PINK1 proteins, performed experiments in duplicate, and used known gain-of-function mutants as positive controls."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The authors calculated OddsPath for the +620 PINK1 variant, which was found to be 12.5."
      }
    ],
    "functional_evidence_strength": "PS3_moderate"
  }
]